The development of hemoglobin-based oxygen carriers (HBOCs) as a blood replacement bridging strategy remains an elusive but much needed objective of transfusion medicine. Complications due HBOC induced vasoactivity and a lack of understanding as to the origins of this effect as well as unanticipated differences in oxygen transport properties of HBOCs and RBC's, have hindered their development and deployment. A fully functional and highly productive consortium of well-established investigators proposes a program project composed of five projects and one cores that will: 1) Expose the underlying mechanism behind vasoactivity complications associated with the infusion of HBOCs, 2) Test new paradigms for HBOC design strategies and 3) Provide a blue print for HBOC design strategies that will allow for the control of vasoactivity and customization for therapeutic applications. The program builds upon an established, on going and highly successful collaborative efforts that have already yielded important new results including: new high yield synthetic strategies for systematic size enhancement of hemoglobins based on surface decoration with polyethylene glycol (PEG), physiology studies showing that the colligative properties of certain PEG decorated hemoglobins result in the elimination of vasoactivity, a new auto-regulatory model to account for vasoactivity and a series of biophysical results that expose functional and conformational consequences of different size enhancement and mutagenic strategies for modifying hemoglobins. The program, with Dr. Friedman as the P.I., will achieve its objectives through an orchestrated interplay among three major themes: molecule design/synthesis, molecule characterization and molecule testing. The program project consists of five projects, and a biochemical core. Project 1 (Acharya, AECOM) and 2 (Ho, Carnegie Mellon) will primarily address design strategies based on chemical and mutagenic modifications respectively. Projects 3 (Friedman, AECOM) and 4 (Peisach, AECOM) will focus on biophysical and functional characterization of surface-decorated and mutagenized HbS. Project 5 (Intaglietta, UCSD) will cover physiological testing of HBOCs. Modified hemoglobins, designed through strategies developed from Projects 1 and 2, will be produced and chemically characterized in the Protein Biochemistry Core (Dr. Manjula, AECOM) in amounts needed for Projects 2(NMR), 3(optical spectroscopy and ligand reactivity), 4(EPR) and 5(physiology).

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Program Projects (P01)
Project #
Application #
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Mondoro, Traci
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
Schools of Medicine
United States
Zip Code
Martucci, Alexandre Fabricio; Abreu Martucci, Ana Carolina Carvalho Ferreira; Cabrales, Pedro et al. (2017) Acute kidney function and morphology following topload administration of recombinant hemoglobin solution. Artif Cells Nanomed Biotechnol 45:24-30
Ao-Ieong, Eilleen S Y; Williams, Alexander; Jani, Vivek et al. (2017) Cardiac function during resuscitation from hemorrhagic shock with polymerized bovine hemoglobin-based oxygen therapeutic. Artif Cells Nanomed Biotechnol 45:686-693
Cabrales, Pedro; Ortiz, Daniel; Friedman, Joel M (2015) NO supplementation for transfusion medicine and cardiovascular applications. Future Sci OA 1:
Krausz, Aimee E; Adler, Brandon L; Cabral, Vitor et al. (2015) Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent. Nanomedicine 11:195-206
Yalcin, Ozlem; Ortiz, Daniel; Williams, Alexander T et al. (2015) Perfusion pressure and blood flow determine microvascular apparent viscosity. Exp Physiol 100:977-87
Anandan, P; Ortiz, D; Intaglietta, M et al. (2015) Red blood cells flows in rectilinear microfluidic chip. Conf Proc IEEE Eng Med Biol Soc 2015:3225-8
Roche, Camille J; Talwar, Abhinav; Palmer, Andre F et al. (2015) Evaluating the capacity to generate and preserve nitric oxide bioactivity in highly purified earthworm erythrocruorin: a giant polymeric hemoglobin with potential blood substitute properties. J Biol Chem 290:99-117
Yalcin, Ozlem; Ortiz, Daniel; Tsai, Amy G et al. (2014) Microhemodynamic aberrations created by transfusion of stored blood. Transfusion 54:1015-27
Ortiz, Daniel; BriceƱo, Juan Carlos; Cabrales, Pedro (2014) Microhemodynamic parameters quantification from intravital microscopy videos. Physiol Meas 35:351-67
Palmer, Andre F; Intaglietta, Marcos (2014) Blood substitutes. Annu Rev Biomed Eng 16:77-101

Showing the most recent 10 out of 104 publications